← Market

X402 · Clinical Trials

NCT ID, title, status, phase, enrollment, sponsor, conditions. Pay 0.001 USDC on Base.

GET https://mcp-x402.onrender.com/x402/clinical-trials

0.001 USDC on Base · payTo 0x5bbd32e0478e49a7540ef2d760e0b0f9aa6328b2

Status: verified · payable

Settlement: via OMNIGATE (https://omnigate.scriptmasterlabs.com) — seller opted in; receipt token per settlement; 0.005 USDC fee inside settlement, waived inside the daily budget

Payment routes

Base · 0.001 USDC · payTo 0x5bbd32e0478e49a7540ef2d760e0b0f9aa6328b2 · via omnigate · settles through OMNIGATE
{
  "term": "diabetes",
  "status": "RECRUITING",
  "rows": 10
}
{
  "source": "clinicaltrials.gov/api/v2",
  "query": {
    "term": "cancer",
    "condition": "",
    "status": "RECRUITING"
  },
  "total": 10,
  "count": 10,
  "trials": [
    {
      "nct_id": "NCT06412172",
      "title": "The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papi",
      "status": "RECRUITING",
      "phase": "",
      "enrollment": 100,
      "conditions": [
        "…",
        "…"
      ],
      "sponsor": "Massachusetts General Hospital",
      "start_date": "2024-04-15",
      "completion_date": "2026-04-14",
      "summary": "Recurrent respiratory papillomatosis (RRP) is an orphan disease that affects app",
      "url": "https://clinicaltrials.gov/study/NCT06412172"
    },
    {
      "nct_id": "NCT05504772",
      "title": "Precision Medicine for Every Child With Cancer",
      "status": "RECRUITING",
      "phase": "",
      "enrollment": 3500,
      "conditions": [
        "…",
        "…"
      ],
      "sponsor": "Australian & New Zealand Children's Haematology/Oncology Group",
      "start_date": "2022-12-16",
      "completion_date": "2025-07",
      "summary": "To improve outcomes for childhood cancer patients through the implementation of ",
      "url": "https://clinicaltrials.gov/study/NCT05504772"
    }
  ],
  "_disclaimer": "Clinical trial reference data. Not medical advice."
}